Salmonella infections in naturally susceptible mice grow rapidly, with
death occurring only after bacterial numbers in vivo have reached a h
igh threshold level, commonly called the lethal load. Despite much spe
culation, no direct evidence has been available to substantiate a role
for any candidate bacterial components in causing death. One of the m
ost likely candidates for the lethal toxin in salmonellosis is endotox
in, specifically the lipid A domain of the lipopolysaccharide (LPS) mo
lecule. Consequently, we have constructed a Salmonella mutant with a d
eletion-insertion in its waaN gene, which encodes the enzyme that cata
lyses one of the two secondary acylation reactions that complete lipid
A biosynthesis, The mutant biosynthesizes a lipid A molecule racking
a single fatty acyl chain and is consequently less able to induce cyto
kine and inducible nitric oxide synthase (iNOS) responses both in vivo
and in vitro. The mutant bacteria appear healthy, are not sensitive t
o increased growth temperature and synthesize a full-length O-antigen-
containing LPS molecule lacking only the expected secondary acyl chain
. On intravenous inoculation into susceptible BALB/c mice, wild-type s
almonellae grew at the expected rate of approximately 10-fold per day
in livers and spleens and caused the death of the infected mice when l
ethal loads of approximately 10(8) were attained in these organs. Some
what unexpectedly, waaN mutant bacteria grew at exactly the same rate
as wild-type bacteria in BALB/c mice but, when counts reached 10(8) pe
r organ, mice infected with mutant bacteria survived. Bacterial growth
continued until unprecedentedly high counts of 10(9) per organ were a
ttained, when approximately 10% of the mice died. Most of the animals
carrying these high bacterial loads survived, and the bacteria were sl
owly cleared from the organs. These experiments provide the first dire
ct evidence that death in a mouse typhoid infection is directly depend
ent on the toxicity of lipid A and Suggest that this may be mediated v
ia proinflammatory cytokine and/or iNOS responses.